Literature DB >> 29471903

Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.

P F Kweza1, C Van Schalkwyk2, N Abraham1, M Uys1, M M Claassens3, A Medina-Marino1.   

Abstract

SETTING: The present study was conducted at 20 randomly selected primary health clinics across Buffalo City Metropolitan Health District, a high TB burden district in South Africa.
OBJECTIVE: To estimate the proportion of TB patients missed by primary health clinics.
DESIGN: We enrolled 1255 TB-symptomatic individuals exiting primary health clinics between March and December 2015. Participants were interviewed and asked to provide sputum for Xpert® MTB/RIF testing.
RESULTS: Clinic staff screened 79.1% of participants seeking care for TB-related symptoms and 21.9% of those attending a clinic for other reasons (P < 0.001). Of those screened by clinic staff, 21.5% reported submitting sputum, although only 9.8% had available results. Study staff tested sputum from 779 participants not tested by clinic staff. Of these, 39 (5.0%) individuals tested positive for TB, three of whom were rifampicin-resistant; 15/39 (38.5%) were never screened and 24/39 (61.5%) were screened but not tested by clinic staff. We estimate that the health system missed 62.9-78.5% of TB patients attending primary health clinics for TB-related symptoms and 89.5-100% of those attending a clinic for other reasons.
CONCLUSION: Low rates of TB screening and testing by the health system resulted in missed TB patients. Universal TB screening and testing of symptomatic individuals should be instituted in high TB burden communities in South Africa.

Entities:  

Mesh:

Year:  2018        PMID: 29471903     DOI: 10.5588/ijtld.17.0491

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  21 in total

1.  "I got tested at home, the help came to me": acceptability and feasibility of home-based TB testing of household contacts using portable molecular diagnostics in South Africa.

Authors:  Andrew Medina-Marino; Lindsey de Vos; Dana Bezuidenhout; Claudia M Denkinger; Samuel G Schumacher; Sanghyuk S Shin; Wendy Stevens; Grant Theron; Martie van der Walt; Joseph Daniels
Journal:  Trop Med Int Health       Date:  2021-01-04       Impact factor: 2.622

2.  Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.

Authors:  Ruvandhi R Nathavitharana; Christina Yoon; Peter Macpherson; David W Dowdy; Adithya Cattamanchi; Akos Somoskovi; Tobias Broger; Tom H M Ottenhoff; Nimalan Arinaminpathy; Knut Lonnroth; Klaus Reither; Frank Cobelens; Christopher Gilpin; Claudia M Denkinger; Samuel G Schumacher
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

Review 3.  Missed opportunities for diagnosis and treatment in patients with TB symptoms: a systematic review.

Authors:  T H Divala; J Lewis; M A Bulterys; V Lutje; E L Corbett; S G Schumacher; P MacPherson
Journal:  Public Health Action       Date:  2022-03-21

4.  Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer.

Authors:  Wencai Tang; Weijin Xing; Chuanzi Li; Zhongshi Nie; Mubin Cai
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

5.  The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.

Authors:  Anthony D Harries; Ajay M V Kumar; Srinath Satyanarayana; Pruthu Thekkur; Yan Lin; Riitta A Dlodlo; Mohammed Khogali; Rony Zachariah
Journal:  Trop Med Infect Dis       Date:  2020-04-16

6.  Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review.

Authors:  Charity Oga-Omenka; Azhee Tseja-Akinrin; Paulami Sen; Muriel Mac-Seing; Aderonke Agbaje; Dick Menzies; Christina Zarowsky
Journal:  BMJ Glob Health       Date:  2020-07

7.  How Can Operational Research Help to Eliminate Tuberculosis in the Asia Pacific Region?

Authors:  Anthony D Harries; Ajay M V Kumar; Srinath Satyanarayana; Pruthu Thekkur; Yan Lin; Riitta A Dlodlo; Rony Zachariah
Journal:  Trop Med Infect Dis       Date:  2019-03-15

8.  Ensuring that Xpert® MTB/RIF is used to its maximum potential.

Authors:  A D Harries; C Timire; K C Takarinda; C Sandy
Journal:  Int J Tuberc Lung Dis       Date:  2019-09-01       Impact factor: 2.373

Review 9.  What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?

Authors:  Anthony D Harries; Yan Lin; Ajay M V Kumar; Srinath Satyanarayana; Kudakwashe C Takarinda; Riitta A Dlodlo; Rony Zachariah; Piero Olliaro
Journal:  F1000Res       Date:  2018-07-05

Review 10.  Quality of TB care among people living with HIV: Gaps and solutions.

Authors:  Kogieleum Naidoo; Santhanalakshmi Gengiah; Satvinder Singh; Jonathan Stillo; Nesri Padayatchi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.